Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Wearable Devices Introduces AI-Powered LLM for Next-Level Gesture Control
-
MREL and MDIV Earn FundGrade A+® Ratings For 2024
-
Reborn Coffee Announces Financing Commitments of up to $60.0 Million
-
Golden Triangle Ventures Announces Destino Ranch as the Premier Global Event Destination
-
Bath & Body Works Declares Cash Dividend
-
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
-
Safety Shot, Inc. Secures Significant Order from Leading Midwestern Grocer, Underscoring Growing Consumer and Retailer Confidence in Sure Shot Brand
-
Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option
-
Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch
-
Empire Communities Strengthens Presence in Charlotte with the Acquisition of SouthCraft Home Builders
-
Ascentage Pharma Announces Partial Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
-
Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study
-
Hampidjan Announces Strategic Investment in Kohinoor Ropes, India
-
Rio2 Announces Official Start of Construction of Fenix Gold Mine
-
iAnthus Strengthens Portfolio with $36.5M Sale of Select Arizona Assets to Sonoran Roots
-
Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans
-
Arq Schedules Q4 & FY 2024 Earnings Conference Call and Upcoming Investor Events
-
ParaZero to Attend IDEX UAE, Leading Defense and Security Exhibition
-
Full House Resorts Announces Fourth Quarter Earnings Release Date
-
Abercrombie & Fitch Co. to Report Fourth Quarter and Full Year 2024 Results on March 5, 2025
-
ITM to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
-
CHAR Tech Announces RSU and Options Grant
-
Arq Provides Update on Transformational GAC Project
-
Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
-
Nusano to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference
-
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
-
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
-
Fitell Corporation Announces $10.0 Million Registered Direct Offering
-
Gray Media Launches New NEXTGEN TV Enhancements for the Big Game on Sunday
-
ARMLOGI HOLDING CORP. TO ANNOUNCE FISCAL 2025 SECOND QUARTER AND SIX-MONTH RESULTS ON THURSDAY, FEBRUARY 13
-
LiveOne (NASDAQ: LVO) to Announce Third Quarter Fiscal Year 2025 Financial Results and Host Investor Webcast on Friday, February 14, 2025
-
Byrna Technologies Reports Record Results for Fiscal Fourth Quarter and Full Year 2024
-
Enlightify Inc. Announces Strategic Partnership with Gaintime Fund to Advance Global Renewable Energy Projects
-
Full House Resorts Announces Fourth Quarter Earnings Release Date
-
Foremost Clean Energy Announces Commencement of Trading of its Spin-Out, Rio Grande Resources
-
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conferenc
-
Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
-
Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
-
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference
-
CLEAR Launches New Lanes at Portland International Airport
-
Abercrombie & Fitch Co. to Report Fourth Quarter and Full Year 2024 Results on March 5, 2025
-
ITM to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
-
Alliance Witan PLC - Net Asset Value
-
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
-
Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock
-
Ekspress Grupp disputes the Lithuanian Competition Council's decision regarding Lrytas acquisition
-
Annual Financial Report 2024
-
CoinEx Launches New Slogan "Your Crypto Trading Expert," Leading a New Era in Crypto Trading Services
